Why is it up .55 today? I suspect Dacogen has make taken a greater share of Vidazza sales away. Now 6 months and doctors who recommend these drugs have a better understanding the benefits Dacogen offers. I would not be surprised if Dacogen has about 50% of market. Could we hear about 1200-1500 vials a week? JNJ update on Dacogen progress should be forthcoming...approval in EU would easily double sales. Watch for news in one of these areas.
Billy T only looks at things one way...his way. He will spin it the way he wants too. Supg has lost it mojo lately. Eanings was spun negatively for the 3rd quarter; the lizard it up to its own tricks; and I don't have a clue for now. Like I ever did, hahaha.
You are right you have no clue. Your the worst kind of long. You want credit when it goes up and want to blame others when it falls. You actually are worse than the bashers. You have been caught posting inconsistancies and draw the criticism of both sides. Only a true idoit would be able to accomplish that. This is a long term hold and if you don't have the conviction on your investment DD then sell.
Until insiders start to sell...we have nothing to worry about. Third quarter news is old and 2007 is setting up to be strong. I point out the positives and look for the negatives...the company has there hands tied with updates coming from MGI and JNJ. But this news is coming...and I can live with that. It's time to grow up Roryrae...
1200 vials a week may not be out of reason. The J code had to boast the number of doctors using Dacogen. The admission of PHRM CEO stating that Dacogen benefitted patients when Vidazza couldn't. That shows a huge advantage over Vidazza and indicates that Dacogen maybe the first preference, now? If we see update of 1200 vials a week that would be 75M+ sales annually on Dacogen and growing. For every 100 vials additional per week increases sales annually by 6.25M.